About the AMR Industry Alliance
r&d pharama
biotechs
diagnostics
biotechs
what we do
- We drive and measure the life-sciences industry progress to curb antimicrobial resistance.
- We want to ensure that we collectively deliver on the specific commitments made in the Declaration (January 2016) and the Roadmap (September 2016) and measure our progress in the fight against antimicrobial resistance.
- We track progress in four different areas (Research and Science, Access, Appropriate Use, and Environment), identify gaps and set targets for the future.
research & science
appropriate use
environment
access
Why the AMR Industry Alliance
Antimicrobial resistance poses a formidable threat to the attainment of the Sustainable Development Goals (SDGs).
The United Nations called in 2016 for concerted action from governments and various sectors to address the implications of antimicrobial resistance in a comprehensive manner, and implement strategies at national level.